Robin Jones to Receptor, IGF Type 1
This is a "connection" page, showing publications Robin Jones has written about Receptor, IGF Type 1.
Connection Strength
0.086
-
Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside. Cancer J. 2010 May-Jun; 16(3):183-94.
Score: 0.086